The cardiac ablation market growth is driven by the rising prevalence of cardiac arrhythmias, increasing awareness of minimally invasive treatment options, and technological advancements in ablation ...
"Radiofrequency Ablation Devices Market"DelveInsight's New Report Reveals 11.16% CAGR Growth, Spotlighting AI Integration, Key Players, and Regional Dynamics Reshaping Global Radiofrequency Ablation ...
The report offers comprehensive statistics, market size analysis, regional shares, and competitor insights. The oncology ...
Pulsed field ablation (PFA), a technology now approved in Europe but not yet licensed in the United States, achieved noninferiority to conventional thermal ablation for the treatment of atrial ...
Radiofrequency (RF) catheter ablation has been a standout success in some forms of atrial fibrillation (AF) but not an unqualified success — it doesn't always work and has safety issues and other ...
“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...
Medtronic has secured the first FDA green light for a pulsed field ablation system, bringing a new type of atrial fibrillation treatment to the U.S. By using short bursts of specifically tuned ...
CHICAGO (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for ...
CINCINNATI (WKRC) - Cardiologists at TriHealth Heart and Vascular Institute are among the first in the nation to use a new device that corrects heart rhythm. The device goes inside the heart. It then ...
Endometrial ablation devices are used to remove the endometrium, which is the lining of the uterus. This procedure used for treatment of menorrhagia when it is not controlled with the help of ...
A medical device company focused on specific minimally invasive cardiac surgeries has moved from Boston to Cleveland hoping to collect $1.5 million and develop its product. Securus Medical Group is ...
CHICAGO (Reuters) - Johnson & Johnson's ablation device outperformed drug therapy for the heart rhythm disorder atrial fibrillation in a study that will be used to seek U.S. regulatory approval for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results